A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...

A flu vaccine that harnesses the messenger RNA technology that ended the COVID-19 pandemic appears increasingly likely, ...

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published ...

More than 18,000 adults took part in the Phase 3 trial during the 2022–2023 flu season. Some received Pfizer’s mRNA flu shot, ...

HealthDay News — A quadrivalent nucleoside-modified messenger RNA (modRNA) influenza vaccine is superior to a licensed inactivated quadrivalent influenza vaccine, according to a study published in the ...

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...

To many scientists and doctors, messenger RNA vaccines are an incredible feat of modern medicine. But to top health leaders in the Trump administration, shots made with the technology pose more risks ...

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger ...

Correcting misinformation after it has gone viral is a common way of informing the public that what they've encountered may ...

KING OF PRUSSIA, Pa. & SAN DIEGO--(BUSINESS WIRE)-- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the publication in Lancet Infectious ...